Podcast: Play in new window | Download
Discover more from Marathon Money +
Subscribe to get the latest posts sent to your email.
In an in-depth conversation with Ryan Confer, CEO of Genprex (GNPX), we explored the company’s dynamic pipeline, including lead candidates like Reqorsa® Gene Therapy for lung cancer and GPX-002 for diabetes. Ryan shared insights into their impressive $100 million funding raise, detailing the company's strategic goals for the upcoming year. He highlighted ambitious milestones around partnerships and collaborations that are propelling Genprex forward in both oncology and diabetes.
We dove into the technical aspects of Genprex's innovative therapies, discussing how each drug functions uniquely to target challenging diseases and how these therapies stand out amid industry competition. Ryan also shared his vision for when these therapies could reach the market, painting a clear picture of where Genprex sees itself in the future and how they plan to impact patient lives on a global scale.
Listen to the Free Version of Marathon Money
Podcast: Play in new window | Download
Subscribe to get the latest posts sent to your email.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Get full access to premium breakdowns, member-only interviews, and step-by-step investing help. Choose a plan below and unlock this post.
Subscribe now to keep reading and get access to the full archive.